The University of Chicago Header Logo

Engineering Challenges and Opportunities in Autologous Cellular Cancer Immunotherapy.

Engineering Challenges and Opportunities in Autologous Cellular Cancer Immunotherapy. J Immunol. 2024 01 15; 212(2):188-198.

View in: PubMed